All filters
Videos
Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study - Tim Cressey, Thailand
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Long-Term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen In Children and Adolescents Living With HIV - Suvaporn Anugulruengkitt, Thailand
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
B/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non- Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial - Alexandra Compagnucci, France
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pediatric HIV Treatment and Prevention: What’s New for 2021 - Martina Penazzato, MD, MSc, PhD
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
The HIV Epidemic in Infants, Children, Adolescents and Women Today – 2021 UNAIDS Update - Mary Mahy, ScD, MHSc
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
ViiV Symposium - Children and Challenges they Face... Our Calling: Optimizing Care in Pediatric HIV Treatment - HIV Pediatrics 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
On Demand Youth Panel - HIV Pediatrics 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Meeting
INTEREST 2022
Abstracts
Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of-Care in the ODYSSEY Trial
C. Kityo
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Early Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries
E. Rabold
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020
D. Carpenter
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review
L. Evitt
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial
A. Compagnucci
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
B/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers
E. Natukunda
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Long-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIV
S. Anugulruengkitt
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019
K. Brooks
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study
T. Cressey
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa
R. Brenner
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial
H. Mujuru
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Dolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-Tanzania
E. Masunga
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa
C. Davies
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021